Search Results - "Piroth, M.D"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas: Results of a prospective phase II study by Piroth, M.D., Pinkawa, M., Holy, R., Klotz, J., Schaar, S., Stoffels, G., Galldiks, N., Coenen, H.H., Kaiser, H.J., Langen, K.J., Eble, M.J.

    Published in Strahlentherapie und Onkologie (01-04-2012)
    “…Purpose Dose escalations above 60 Gy based on MRI have not led to prognostic benefits in glioblastoma patients yet. With positron emission tomography (PET)…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer: Matched-pair analysis by Pinkawa, M., Piroth, M.D., Holy, R., Escobar-Corral, N., Caffaro, M., Djukic, V., Klotz, J., Eble, M.J.

    Published in Strahlentherapie und Onkologie (01-10-2012)
    “…Background Hydrogel spacer is an innovative method to protect the rectal wall during prostate cancer radiotherapy. Clinical effects are not well known. Methods…”
    Get full text
    Journal Article
  12. 12

    Treatment planning after hydrogel injection during radiotherapy of prostate cancer by Pinkawa, M., Bornemann, C., Escobar-Corral, N., Piroth, M.D., Holy, R., Eble, M.J.

    Published in Strahlentherapie und Onkologie (01-09-2013)
    “…Purpose Imaging for treatment planning shortly after hydrogel injection is optimal for practical purposes, reducing the number of appointments. The aim was to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Radiation recall dermatitis from docetaxel by Piroth, M D, Krempien, R, Wannenmacher, M, Zierhut, D

    Published in Onkologie (01-10-2002)
    “…Experiences with inflammatory skin reactions after treatment with docetaxel and prior exposure to radiotherapy like a recall phenomenon are very rare. We…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19